
Danbaxy Pharmaceuticals Private Limited
Founded in 2001 and headquartered in Maharashtra, India.
Founded in 2001 and headquartered in Maharashtra, India.
Thane, Maharashtra, India
+91-XXXXXXXXXX
U24239MH2001PTC132118
132118
Private Limited Indian Non-Government Company
25 May 2001
30 Sep 2022
31 Mar 2022
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rajiv Singh ![]() | Director | 25-May-2001 | Current |
Premsheela Singh ![]() | Director | 04-Mar-2009 | Current |
Danbaxy Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2017, Danbaxy Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Danbaxy Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Danbaxy Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Danbaxy Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Danbaxy Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Danbaxy Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai.
Premsheela Rajiv Singh was appointed as a Director was appointed as a Director on 04 Mar 2009 & has been associated with this company since 16 years 2 months .
Rajiv Ranjan Kumar Singh was appointed as a Director was appointed as a Director on 25 May 2001 & has been associated with this company since 23 years 11 months .
Danbaxy Pharmaceuticals Private Limited was registered on 25 May 2001 with Roc Mumbai & aged 23 years 11 months as per MCA records.
Danbaxy Pharmaceuticals Private Limited was incorporated on 25 May 2001.
The authorized share capital of Danbaxy Pharmaceuticals Private Limited is ₹ 2.50 M and paid-up capital is ₹ 1.82 M.
Currently 2 directors are associated with Danbaxy Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Danbaxy Pharmaceuticals Private Limited is Cfc Plot No.11 Dewan 7 Sons Udyog Nagar, Lokmanya India, Palghar West, Maharashtra, 401404.
The corporate identification number (CIN) of Danbaxy Pharmaceuticals Private Limited is U24239MH2001PTC132118 and the company number is 132118 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Danbaxy Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2022.
Search company & director profiles for free and gain access to critical business data.
RS